Medical Company for Sale, or Out-License

The company has begun marketing efforts but decided to sell the company or out-license to a larger strategic buyer that has the capacity to aggressively market the company. The company developed a patented surgical navigation system for interventional procedures such as biopsy, tumor ablation, pain management, particle implantation, etc. The company specializes in 3D medical imaging software, image process algorithms, virtual reality, and tracking technology. The device received FDA clearance in 2014 and China FDA clearance in 2022. The CE Mark will be the next clearance received. The device applies electromagnetic tracking technology for navigation without requiring a line of sight, while other navigation systems apply infrared light tracking technology that does not allow for the line of sight to be blocked.